Severe toxic shock syndromes and superantigen reactions triggered by mold

Categories of Mold-Related Superantigen Responses:

- Allergen: The human body produces IgE antibodies to recognize, destroy, and remember specific mold antigens.

- Pathogen: Mold colonizes and multiplies to infectious levels in warm, moist environments, such as the sinuses, lungs, or even on the skin.

- Toxigen: Several types of mold, particularly those associated with water-damaged buildings, produce potent mycotoxins. These toxins cause a wide range of powerful toxic effects in organ systems. They are classified as carcinogenic, mutagenic, teratogenic, estrogenic, hemorrhagic, immunotoxic, nephrotoxic, hepatotoxic, dermatotoxic, and neurotoxic.

- Superantigenic or Superantigen-Like Immune Response: Certain mold infections, either alone or in combination with bacterial endotoxins in biofilms, can trigger a life-threatening immune response known as a "cytokine storm."

Superantigenic Responses

Some infections, accompanied by a superantigenic response to mold or another co-occurring microbial infection, are known as cytokine storms. A cytokine storm is a specific type of severe immune system reaction in which cytokines are rapidly produced and begin to attack the body. Although this is a complex phenomenon, the superantigenic response is markedly different from the body's traditional reactions to mold. Patients experience a severe, life-threatening condition that requires immediate hospitalization. It often presents as sepsis or a severe blood infection, which must be promptly managed, or it can be fatal. Mortality rates in such cases are very high if urgent medical intervention is not provided.

Mold allergies are treated with antihistamines and steroids. Pathogenic mold infections are removed surgically or treated with a limited number of powerful antifungal drugs, which themselves can be toxic. Mold mycotoxins, if detected, are treated over time with very specific detoxification protocols involving dietary supplements, lifestyle changes, environmental vigilance, and dietary restrictions.

Superantigenic reactions are associated with various systemic mold infections. In these cases, superantigenic responses lead to an immediate, massive immune system activation. These life-threatening reactions are known as cytokine storms. A patient with a fungal respiratory infection may end up in the emergency room with symptoms indicating acute infections such as those seen in sepsis, scarlet fever, systemic skin infections, toxic shock syndrome, or food poisoning, or may trigger or exacerbate another autoimmune disease.

History of Superantigen Identification

The term "toxic shock syndrome" (TSS) was first coined by doctors in the late 1970s and early 1980s to describe infections caused by Staphylococcus and Streptococcus bacteria. It was discovered that highly absorbent tampons, commonly used by menstruating women, were the cause. The result was a superinfection due to an intense activation of the autoimmune response, particularly among certain T-cell subgroups. Following changes in tampon production, the incidence of tampon-related TSS significantly decreased. However, similar toxic shock cases continue to be treated in hospitals.

The term "superantigen" was introduced by researchers in 1990. Prior to this, TSS was attributed to pyrogenic toxins from T-cell superantigens, mainly from *Staphylococcus aureus* and *Streptococcus*. Over time, newly discovered superantigens were identified as proteins produced by microbes, which were found to be associated with various human diseases. These include TSS, atopic dermatitis, infectious endocarditis, pneumonia, sepsis, meningitis, and autoimmune diseases. Streptococcal TSS is most commonly observed in children and the elderly. Other at-risk groups include individuals with diabetes, weakened immune systems, chronic lung diseases, or heart conditions.

Superantigens in Disease

According to the Encyclopedia of Infectious Diseases, "Bacterial superantigen responses have been implicated as a cause of a range of acute pathological conditions, including food poisoning, staphylococcal sepsis-associated toxic shock, toxic shock syndrome, scalded skin syndrome, and scarlet fever. A common feature of these diseases is massive systemic immune activation, reflected in elevated levels of serum cytokines, the body's chemical messengers. The accompanying toxic shock is likely at least partially due to excessive cytokine release." Additionally, superantigens are believed to play a role in the pathogenesis of certain viruses, including HIV and COVID.

Doctors who typically treat upper and lower respiratory tract infections, such as chronic rhinosinusitis (CRS) and bronchitis, rarely encounter these life-threatening immune reactions that affect the entire body. In such cases, patients often end up in emergency rooms, where immediate treatment is required for severe systemic infections, such as sepsis, scarlet fever, atopic dermatitis, or food poisoning. Diagnoses and treatment are often carried out without a complete patient history or knowledge of the underlying cause.

Superantigenic or superantigen-like immune responses have also been observed in fungal and viral infections (e.g., HIV, COVID-19, and Long COVID). The large number of COVID patients during the pandemic provided the necessary cases to link COVID with superantigenic responses. As a result, there is growing interest in studying severe inflammatory reactions and life-threatening complications associated with systemic mold infections and chronic mold exposure in the environment. Many scientists now believe that mold spores, debris, and toxins can trigger superantigenic reactions.

Superantigenic Response in Perspective

To put this into perspective, a typical immune response to a microbial antigen involves a modest immune reaction, usually activating 0.0001–0.01% of the body's T-cells. In contrast, exposure to a superantigen can activate up to 30% of the body's entire T-cell population. This represents an increase of over 3,000 times more T-cells and other immune modulators. An excessive and nonspecific immune response to superantigens can lead to severe syndromes, including fever, shock, and organ failure, all of which are life-threatening conditions. By comparison, the response to a normal antigen is usually more controlled and targeted, aimed at eliminating the specific pathogen or foreign substance in question. A superantigen response, on the other hand, triggers a cytokine storm, caused by a rapid and overwhelming reaction of the adaptive immune system.

Understanding the Immune System

Our bodies have two types of immunity: innate and adaptive. Our innate immunity (also known as cell-mediated immunity) responds immediately to foreign antigens. It consists of anatomical barriers and cellular responses. Anatomical barriers include the skin, mucous production, stomach acids, bile acids from the liver, tear production, sweat, and the blood-brain barrier. Internally, our innate immunity also has an immediate cellular response to antigens. The cell-mediated immune response involves the production of eosinophils and cytokines that seek out, destroy, and eliminate microbes that enter the body. It is carried out by white blood cells, such as leukocytes, monocytes, natural killer cells, and macrophages. Cytokines are chemical mediators that prevent the spread of infection and protect uninfected cells from becoming infected. There are several types of cytokines, including chemokines, interferons, interleukins, and tumor necrosis factors.

Adaptive immunity takes time for the body to recognize antigens and produce antibodies that specifically seek out, destroy, and remember foreign antigens. It can take weeks or longer to produce these antibodies.

Superantigen Response

A superantigen is a type of antigen that causes an excessive and nonspecific immune response in the body. Regular antigens stimulate only a small subset of T-cells. Superantigens, however, can activate an excessive number of T-cells by directly binding to the T-cell receptor (TCR) and class II major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs).

The resulting immune response involves the release of chemical messengers known as cytokines. Cytokines are very small, unstructured chemical messengers secreted by various cells in the body. They function by helping regulate inflammatory and immune responses. Many of the cells that secrete cytokines are white blood cells, such as lymphocytes and monocytes.

A cytokine storm occurs when the body overproduces T-cells, which then begin to attack the body. Superantigens are responsible for diseases such as toxic shock syndrome and necrotizing fasciitis. They are also linked to autoimmune diseases and certain types of cancer.

Superantigens in Literature

Over the past 20 years, superantigens or "superantigenic" proteins have been identified in various microbes, including viruses and fungi. The reactions caused by these superantigens are of serious concern to medical specialists due to their ability to trigger life-threatening systemic immune responses that attack the body. Moreover, patients with chronic rhinosinusitis (CRS) and other respiratory infections often show evidence of both fungal and bacterial infections.

Dr. Donald Dennis, an ENT specialist, first published findings on this phenomenon in 2003, focusing on his practice with patients suffering from CRS. It is well known that refractory infections can be caused by biofilm formation, which protects microbes by creating an extracellular matrix. Dr. Dennis provided further insights into the treatment of systemic mycotoxicosis resulting from chronic sinusitis.

Fungi can also invade the lungs through direct infection of lung tissue, contamination of pulmonary air spaces or cavities, or by triggering an immune response when fungal materials are inhaled. Fungi are believed to act as immunogenic antigens and contribute to inflammation through protease activity, and are associated with allergic asthma.

"The connection between allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypertrophic sinusitis with class II MHC genes places the onset of these inflammatory diseases in the context of antigen presentation and acquired immune response. Pathological immune manipulation by local microbial superantigens may be a common mechanism in disease pathogenesis. Future studies on the molecular biology of these related conditions may provide insights into the pathogenesis of other chronic inflammatory diseases."

Mold Mycotoxins

Some species of mold can produce mycotoxins, which are secondary metabolites capable of causing a range of health issues depending on the type and level of exposure. Mycotoxins have been linked to various symptoms, including respiratory problems, skin irritation, headaches, and fatigue. It is important to note that mycotoxins are chemical compounds, not living organisms.

On Superantigens

Superantigens have attracted considerable attention since their mechanisms were first understood in the late 1980s. Since then, numerous cases and studies have been published about their structure and molecular mechanisms. However, there has been limited information published about their direct role in diseases, aside from obvious cases of food poisoning and toxic shock. Nonetheless, there has been much speculation that superantigens are involved in severe immune diseases and infections.

Fungal "superantigens" are a particular type of protein produced by certain fungi that can activate a large number of T-cells, leading to an excessive immune response that can result in tissue damage and inflammation. While several superantigens have been documented for bacteria and viruses, the identification of fungal superantigens remains an active area of research, with only a few examples reported so far.

Here are some examples of non-bacterial "superantigens":

- Staphylococcal enterotoxin B proteins from *Aspergillus fumigatus* (Reported but not proven)

- Superantigen-like effects of *Candida albicans* polypeptides

- Superantigen encoded by HIV

- Staphylococcal enterotoxin protein from *Aspergillus flavus* (Superantigenic reactions reported but not proven)

- SARS-CoV-2 as a superantigen, superantigen-like protein, or a pathogen triggering a superantigenic host response

It is important to note that the fungal kingdom is vast, and most species have yet to be isolated or identified. The discovery of new superantigens is in its early stages, and the list is likely to expand in the future.

The Role of Biofilms in Superantigen Reactions

Another plausible explanation for superantigen reactions is the recognition that many respiratory infections are initiated by biofilm development. Biofilms can form when tissue walls are damaged by foreign antigens. The immediate response of eosinophils may cause additional damage. A biofilm is a surface matrix formation that brings together and protects a variety of microbes, including bacteria and fungi. It is clear that patients who develop fungal or bacterial infections may be exposed to staphylococcal or streptococcal endotoxins that trigger a superantigen response.

Conclusion

While further research is necessary to explain the specific pathology of superantigen reactions, the recognition of cytokine storms has been well-documented in emergency departments across the country. These unexplained life-threatening infections are widespread. Unfortunately, emergency room protocols do not exhaust all diagnostic possibilities when treating severe infections in acute situations. Evidence suggests that the historical toxic shock syndrome (TSS) caused by bacterial endotoxins may have other potential microbial sources. The availability of data collected during the COVID pandemic suggests alternative causes of cytokine storms. Additionally, the role of biofilms in serious infections provides an explanation for the difficult-to-treat nature of these severe conditions.

References:

1. Kalland, et. al. Superantigens in Disease, Encyclopedia of Immunology (Second Edition), 1998

2. Schubert, M. “A Superantigen Hypothesis for The Pathogenesis of Chronic Hypertrophic Rhinosinusitis, Allergic Fungal Sinusitis, And Related Disorders.” Annals of Allergy and Asthma Immunology. September 2001.

3. “Prevalence of Fungal and Bacterial Co-Infection in Pulmonary Fungal Infections: A Metagenomic Next Generation Sequencing-Based Study.” Frontiers in Cellular and Infectious Biology. Nov. 1, 2021.

4. Dennis, Donald. “Chronic Sinusitis: Defective T-cells Responding to Superantigen Treated by Reduction of Fungus in the Nose and Air.” Archives of Environmental Health. August 2003

5. Dennis, Donald. et.al. “Surgical and Medical Management of Sinus Mucosal and Systemic Mycotoxicosis.” Journal of Otolaryngology and Reconstructive Surgery. April 24, 2017.

6. Donlan, Rodney, Center of Disease Control, Atlanta, GA. “Biofilms: microbial life on surfaces.” Emerging Infectious Disease. Sept. 8 2002

7. Schubert, M.S. “Allergic Fungal Sinusitis” Clinical Review of Allergy and Immunology. 30, 205-215. 2006.

8. Ickratyh, P. “Aspergillus fumigatus-Specific T Cells in Patients with Chronic Rhinosinusitis.” International Archives Allergy and Immunology. January 18, 2023.

9. Devore-Carter, Denise. “Superantigen-Like Effects of a Candida albicans Polypeptide.” Journal of Infectious Disease. April 1, 2008.

10. Torres, B. “Mechanism of HIV pathogenesis: Role of Superantigen in Disease.” Alcohol Clinical Experimental Research. Aug 22, 1998

11. Dolen, W. “Risk factors for allergic Aspergillus sinusitis” Medical Mycology, Volume 44, Issue Supplement 1, September 2006

12. Rudramurthy, S. “Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management.” Journal Fungi (Basel). September 5, 2019

13. Bose, P. “Is SARS-CoV-2 a Superantigen?” Lifescience and Medical News. March 29, 2023

14. Saluja, R. et. al. “Role and relevance of mast cells in fungal infections,” Frontiers in Immunology. Front Immunol. June 13, 2012.

15. Shin, H. “Role of Fungal and Bacterial Superantigen in the Pathogenesis of Chronic Rhinosinusitis with Polyps.” Journal of Rhinology. November 30, 2008.

16. Ponikau, J U et. al. « The Diagnosis and Treatment of Chronic Allergic Fungal Sinusitis.” Mayo Clinic Proceedings. September 1999.